NASDAQ:EDIT   EDITAS MEDICINE INC
146 2 5
High end biotech early stage CRISPR .. the bitcoin of biotech
JPariz
9 months ago
There are a few efforts to use CRISPR to treat or even cure blindness in humans. Researchers have successfully removed a genetic mutation from mice that causes retinitis pigmentosa, a disease that ultimately leads to blindness. After a single injection of the CRISPR/Cas9 system, the rats were able to see better than a control group. Plans to use a similar technique on humans are already underway. Biotechnology company Editas Medicine is planning to use CRISPR to treat the inherited eye disease leber's congenitial amaurosis (LCA) by 2017.
Reply
JPariz
9 months ago
yea naysayers can suck it now thanks :)
Reply
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out